Vivos Therapeutics's market cap is currently $19.38M. The company's EPS TTM is $-4.946; its P/E ratio is ―; Vivos Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 13.80M	$ 16.02M	$ 16.89M	$ 13.07M	$ 11.39M
Gross Profit	$ 8.27M	$ 10.02M	$ 12.60M	$ 10.41M	$ 8.66M
Operating Income	$ -17.30M	$ -25.03M	$ -19.47M	$ -8.71M	$ -10.58M
EBITDA	$ -16.68M	$ -24.36M	$ -19.54M	$ -11.24M	$ -9.87M
Net Income	$ -13.58M	$ -22.66M	$ -20.29M	$ -8.82M	$ -10.89M
Balance Sheet
Cash & Short-Term Investments	$ 1.64M	$ 3.52M	$ 24.03M	$ 18.21M	$ 469.35K
Total Assets	$ 10.73M	$ 13.72M	$ 33.69M	$ 25.33M	$ 7.55M
Total Debt	$ 2.00M	$ 2.41M	$ 1.63M	$ 1.29M	$ 3.71M
Net Debt	$ 352.00K	$ -1.11M	$ -22.40M	$ -16.92M	$ 3.24M
Total Liabilities	$ 10.32M	$ 8.92M	$ 8.15M	$ 8.41M	$ 10.49M
Stockholders' Equity	$ 411.00K	$ 4.80M	$ 25.54M	$ 16.92M	$ -2.94M
Cash Flow
Free Cash Flow	$ -12.75M	$ -20.51M	$ -18.13M	$ -5.80M	$ -5.52M
Operating Cash Flow	$ -11.95M	$ -19.59M	$ -15.73M	$ -5.68M	$ -5.34M
Investing Cash Flow	$ -853.00K	$ -924.00K	$ -2.61M	$ -120.25K	$ 86.22K
Financing Cash Flow	$ 10.92M	$ 0.00	$ 24.17M	$ 23.54M	$ 4.47M

Currency in USD

Vivos Therapeutics Earnings and Revenue History

Income Statement >

Vivos Therapeutics Debt to Assets

Balance Sheet >

Vivos Therapeutics Cash Flow

Cash Flow >

Vivos Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing